Virax Biolabs Group Limited (VRAX) Options Chain

The options chain displays all available contracts with end-of-day quotes, Greeks, volume, and open interest for each strike and expiration, and streams live quotes for traders who connect a broker. It is the primary tool for options trade selection.

Virax Biolabs Group Limited (VRAX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $526,283, listed on NASDAQ, employing roughly 26 people, carrying a beta of 1.34 to the broader market. Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Led by James Foster, public since 2022-07-21.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for VRAX as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →